These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 12606318)

  • 1. Characterization of a lanosterol 14 alpha-demethylase from Pneumocystis carinii.
    Morales IJ; Vohra PK; Puri V; Kottom TJ; Limper AH; Thomas CF
    Am J Respir Cell Mol Biol; 2003 Aug; 29(2):232-8. PubMed ID: 12606318
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activity of Isavuconazole and Other Azoles against Candida Clinical Isolates and Yeast Model Systems with Known Azole Resistance Mechanisms.
    Sanglard D; Coste AT
    Antimicrob Agents Chemother; 2016 Jan; 60(1):229-38. PubMed ID: 26482310
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening for amino acid substitutions in the Candida albicans Erg11 protein of azole-susceptible and azole-resistant clinical isolates: new substitutions and a review of the literature.
    Morio F; Loge C; Besse B; Hennequin C; Le Pape P
    Diagn Microbiol Infect Dis; 2010 Apr; 66(4):373-84. PubMed ID: 20226328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amino acid substitutions in the cytochrome P-450 lanosterol 14alpha-demethylase (CYP51A1) from azole-resistant Candida albicans clinical isolates contribute to resistance to azole antifungal agents.
    Sanglard D; Ischer F; Koymans L; Bille J
    Antimicrob Agents Chemother; 1998 Feb; 42(2):241-53. PubMed ID: 9527767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contribution of mutations in the cytochrome P450 14alpha-demethylase (Erg11p, Cyp51p) to azole resistance in Candida albicans.
    Marichal P; Koymans L; Willemsens S; Bellens D; Verhasselt P; Luyten W; Borgers M; Ramaekers FCS; Odds FC; Vanden Bossche H
    Microbiology (Reading); 1999 Oct; 145 ( Pt 10)():2701-2713. PubMed ID: 10537192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heterologous Expression of Full-Length Lanosterol 14α-Demethylases of Prominent Fungal Pathogens Candida albicans and Candida glabrata Provides Tools for Antifungal Discovery.
    Keniya MV; Ruma YN; Tyndall JDA; Monk BC
    Antimicrob Agents Chemother; 2018 Nov; 62(11):. PubMed ID: 30126959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A newly identified amino acid substitution T123I in the 14α-demethylase (Erg11p) of Candida albicans confers azole resistance.
    Wu Y; Gao N; Li C; Gao J; Ying C
    FEMS Yeast Res; 2017 May; 17(3):. PubMed ID: 28334124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple amino acid substitutions in lanosterol 14alpha-demethylase contribute to azole resistance in Candida albicans.
    Favre B; Didmon M; Ryder NS
    Microbiology (Reading); 1999 Oct; 145 ( Pt 10)():2715-25. PubMed ID: 10537193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An Erg11 lanosterol 14-α-demethylase-Arv1 complex is required for Candida albicans virulence.
    Villasmil ML; Barbosa AD; Cunningham JL; Siniossoglou S; Nickels JT
    PLoS One; 2020; 15(7):e0235746. PubMed ID: 32678853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic basis for differential activities of fluconazole and voriconazole against Candida krusei.
    Fukuoka T; Johnston DA; Winslow CA; de Groot MJ; Burt C; Hitchcock CA; Filler SG
    Antimicrob Agents Chemother; 2003 Apr; 47(4):1213-9. PubMed ID: 12654649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced Susceptibility to Azoles in Cryptococcus gattii Correlates with the Substitution R258L in a Substrate Recognition Site of the Lanosterol 14-α-Demethylase.
    Carvajal SK; Melendres J; Escandón P; Firacative C
    Microbiol Spectr; 2023 Aug; 11(4):e0140323. PubMed ID: 37341584
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The amino acid substitution N136Y in Candida albicans sterol 14alpha-demethylase is involved in fluconazole resistance.
    Alvarez-Rueda N; Fleury A; Logé C; Pagniez F; Robert E; Morio F; Le Pape P
    Med Mycol; 2016 Oct; 54(7):764-775. PubMed ID: 27143634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contribution of clinically derived mutations in ERG11 to azole resistance in Candida albicans.
    Flowers SA; Colón B; Whaley SG; Schuler MA; Rogers PD
    Antimicrob Agents Chemother; 2015 Jan; 59(1):450-60. PubMed ID: 25385095
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of Homologous Resistance Mutations from Pathogenic Yeast on Saccharomyces cerevisiae Lanosterol 14α-Demethylase.
    Sagatova AA; Keniya MV; Tyndall JDA; Monk BC
    Antimicrob Agents Chemother; 2018 Mar; 62(3):. PubMed ID: 29263059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Y132H substitution in Candida albicans sterol 14alpha-demethylase confers fluconazole resistance by preventing binding to haem.
    Kelly SL; Lamb DC; Kelly DE
    FEMS Microbiol Lett; 1999 Nov; 180(2):171-5. PubMed ID: 10556708
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Facultative sterol uptake in an ergosterol-deficient clinical isolate of Candida glabrata harboring a missense mutation in ERG11 and exhibiting cross-resistance to azoles and amphotericin B.
    Hull CM; Parker JE; Bader O; Weig M; Gross U; Warrilow AG; Kelly DE; Kelly SL
    Antimicrob Agents Chemother; 2012 Aug; 56(8):4223-32. PubMed ID: 22615281
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Three-dimensional models of 14α-sterol demethylase (Cyp51A) from Aspergillus lentulus and Aspergillus fumigatus: an insight into differences in voriconazole interaction.
    Alcazar-Fuoli L; Cuesta I; Rodriguez-Tudela JL; Cuenca-Estrella M; Sanglard D; Mellado E
    Int J Antimicrob Agents; 2011 Nov; 38(5):426-34. PubMed ID: 21871783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cloning and characterization of the lanosterol 14alpha-demethylase (ERG11) gene in Cryptococcus neoformans.
    Revankar SG; Fu J; Rinaldi MG; Kelly SL; Kelly DE; Lamb DC; Keller SM; Wickes BL
    Biochem Biophys Res Commun; 2004 Nov; 324(2):719-28. PubMed ID: 15474487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aspergillus fumigatus CYP51 sequence: potential basis for fluconazole resistance.
    Edlind TD; Henry KW; Metera KA; Katiyar SK
    Med Mycol; 2001 Jun; 39(3):299-302. PubMed ID: 11446535
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deletion of the Candida glabrata ERG3 and ERG11 genes: effect on cell viability, cell growth, sterol composition, and antifungal susceptibility.
    Geber A; Hitchcock CA; Swartz JE; Pullen FS; Marsden KE; Kwon-Chung KJ; Bennett JE
    Antimicrob Agents Chemother; 1995 Dec; 39(12):2708-17. PubMed ID: 8593007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.